Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
AIM ImmunoTech Inc. announces that its core drug Ampligen® has reached a critical value inflection point in the field of pancreatic cancer treatment.

AIM ImmunoTech Inc. announces that its core drug Ampligen® has reached a critical value inflection point in the field of pancreatic cancer treatment.

老虎证券老虎证券2026/04/16 13:09
Show original
The company has formulated a plan to launch a phase 3 clinical study targeting pancreatic cancer. This major decision is strongly supported by several factors: including previously observed positive clinical signals, the drug’s orphan drug designation, and the company’s global intellectual property protection layout. Together, these elements form a solid foundation for advancing the study and mark a new and important stage in the company’s strategic progress in tumor immunotherapy.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Apple Releases Developer Preview: AI Listening Feature and New Health App Launched

Apple has officially released the first test versions of iOS 27.3 and watchOS 27.3 to developers, with the full version expected to launch in December. Among the new features, the AI listening function requires the microphone to remain constantly on, enabling real-time monitoring and summarization of nearby conversations, which may potentially violate eavesdropping laws in certain U.S. states. The updated Health app can monitor heart rate, vital signs, step count, and other fitness indicators, and can estimate a user's physiological age based on their health data.

华尔街见闻•2026/11/03 21:27
Apple Releases Developer Preview: AI Listening Feature and New Health App Launched